The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequency Ablation

NCT05732181 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer
Post Ablation Syndrome

Interventions

DRUG: The skin lidocaine patch.
DRUG: Placebo

Sponsor

National Cheng-Kung University Hospital